Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 39, 2020 - Issue 4
196
Views
3
CrossRef citations to date
0
Altmetric
Case Report

IgG4-rich reactive lymphoid hyperplasia of the lacrimal gland

, &
Pages 285-288 | Received 02 Jul 2019, Accepted 27 Oct 2019, Published online: 14 Nov 2019

References

  • Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010;34:202–210. doi:10.1097/PAS.0b013e3181c811ad.
  • Takahira M, Kawano M, Zen Y, et al. IgG4-related chronic sclerosing dacryoadenitis. Arch Ophthalmol. 2007;125:1575–1578. doi:10.1001/archopht.125.11.1575.
  • Jakobeic FA, Stac RC, Hehta M, Fay A. IgG4-positive dacryoadenitis and Küttner submandibular sclerosing inflammatory tumor. Arch Ophthalmol. 2010;128:942–944. doi:10.1001/archophthalmol.2010.112.
  • Geyer JT, Deshpande V. IgG4-associated sialadenitis. Curr Opin Rheumatol. 2011;23:95–101. doi:10.1097/BOR.0b013e3283413011.
  • Takano K, Yamamoto M, Takahashi H, et al. Clinicopathologic similarities between Mikulicz disease and Küttner tumor. Am J Otolaryngol. 2010;31:429–434. doi:10.1016/j.amjoto.2009.08.002.
  • Heuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+chronic sclerosing dacryoadenitis: a previously undescribed complicated of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159–1167. doi:10.1097/PAS.0b013e31816148ad.
  • Ochoa ER, Harris NL, Pilch BZ. Marginal zone B-cell lymphoma of the salivary gland arising in chronic sclerosing sialadenitis (Küttner tumor). Am J Surg Path. 2001;25:1546–1550. doi:10.1097/00000478-200112000-00012.
  • Mattoo H, Mahajan VA, Maehara T, et al. Clonal expansion of CD4+ cytotoxic lymphocytes in IgG4-related disease. J Allergy Clin Immunol. 2016;138:825–838. doi:10.1016/j.jaci.2015.12.1330.
  • Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74:14–18. doi:10.1136/annrheumdis-2013-204907.
  • Cheuk W, Yuen HKL, Chu SYY, et al. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:671–681. doi:10.1097/PAS.0b013e318157c068.
  • Sato Y, Yoshino T. IgG4-related lymphadenopathy. Int J Rheumatol. 2012. Article ID 572539. doi:10.1155/2012/572539.
  • Strehl JD, Hartmann A, Sgaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localized non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011;64:237–243. doi:10.1136/jcp.2010.085613.
  • Asano N, Sato Y. Rheumatoid lymphadenopathy with abundant IgG4+ plasma cells: a case mimicking IgG4-related disease. J Clin Exp Hematopathology. 2012;52:57–61. doi:10.3960/jslrt.52.57.
  • Mehta M, Jakobiec F, Ray A. Idiopathic fibroinflammatory disease of the face, eyelids, and periorbital membrane with immunoglolbulin IGg4-positive plasma cells. Arch Pathol Lab Med. 2009;133:1251–1255. doi:10.1043/1543-2165-133.8.1251.
  • Stacy RC, Jakobiec FA, Schoenfield L, Singh AD. Unifocal and multifocal reactive lymphoid hyperplasia vs follicular lymphoma of the ocular adnexa. Am J Ophthalmol. 2010;150:412–426. doi:10.1016/j.ajo.2010.04.007.
  • Bledsoe JR, Wallace ZS, Stone JH, et al. Lymphomas in IgG4-related disease: clinicopathologic features in a Western population. Virchow Arch. 2016;472:839–852. doi:10.1007/s00428-017-2286-9.
  • Bledsoe JR, Wallace ZS, Deshpande V, et al. Atypical IgG4+ plasmacytic proliferations and lymphomas characterization of 11 cases. Am J Clin Pathol. 2017;148:215–235. doi:10.1093/AJCP/AQX067.
  • Mattoo H, Majahan VA, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134:679–687. doi:10.1016/j.jaci.2014.03.034.
  • Witzig TE, Inwards DJ, Habermann TM, et al. Treatment of benign orbital pseudolymphoma with the monoclonal anti-CD20 antibody rituximab. May Clin Proc. 2007;82:692–699. doi:10.1016/S0025-6196(11)61189-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.